{"success":true,"data":{"pressRelease":{"id":"123754","rtpr_id":"nACSYntRla","ticker":"GTM","exchange":"NASDAQ","all_tickers":["GTM"],"title":"$GTM Securities: ZoomInfo Shareholders Who Lost Money after AI Integration Revelation are Notified to Protect their Rights in Securities Fraud Class Action","author":"ACCESSWIRE","published_at":"2026-08-20T11:07:01.085Z","article_body":"A securities fraud class action lawsuit has been filed on behalf of ZoomInfo\ninvestors after its stock plummeted nearly 33% because ZoomInfo allegedly\nmisled investors regarding its customer retention.\n\nNEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / August\n20, 2026 / Leading securities law firm Bleichmar Fonti & Auld LLP\n(https://pr.report/pa9w) announces that a class action lawsuit has been filed\nagainst ZoomInfo Technologies Inc. (NASDAQ:GTM) and certain of the Company's\nsenior executives for securities fraud after its significant stock drop\nresulting from potential violations of the federal securities laws.\n\nIf you invested in ZoomInfo, you are encouraged to obtain additional\ninformation by visiting:\nhttps://www.bfalaw.com/cases/zoominfo-class-action-lawsuit.\n\nKey Details of the ZoomInfo ($GTM) Class Action:\n*\nLead Plaintiff Deadline: August 24, 2026\n*\nAlleged Misconduct: Securities fraud alleging that ZoomInfo misled investors\nregarding the impact of ZoomInfo's AI-integrated products on customer\nretention\n*\nStock Drop: May 12, 2026 - 33% Stock Drop\n*\nCourt: U.S. District Court for the Western District of Washington\n*\nAction: Contact BFA Law (https://pr.report/pa9y) to discuss your rights\n\nInvestors have until August 24, 2026 to ask the Court to be appointed to lead\nthe case. The complaint asserts securities fraud claims under Sections 10(b)\nand 20(a) of the Securities Exchange Act of 1934 on behalf of investors in\nZoomInfo securities. The class action is pending in the U.S. District Court\nfor the Western District of Washington. It is captioned Tejeda v. ZoomInfo\nTechnologies et al., No. 26-cv-05696.\n\nWhy is ZoomInfo Being Sued for Securities Fraud?\n\nZoomInfo has been sued for securities fraud following a significant stock drop\nresulting from potential violations of the federal securities laws. The\ndecline in ZoomInfo's stock price caused significant losses to investors.\n\nZoomInfo provides go-to-market (\"GTM\") intelligence and a customer engagement\nplatform for sales, marketing, operations, and recruiting professionals.\n\nThroughout the relevant period, ZoomInfo allegedly stated that \"the demand for\nAI for GTM is evident up and down our customer stack.\" According to ZoomInfo,\nits \"innovative go-to-market AI\" was \"driving stronger daily engagement from a\ndiverse set of go-to-market personas.\"\n\nOn February 9, 2026, ZoomInfo issued its 2026 revenue guidance \"in the range\nof $1.247 billion to $1.267 billion,\" because \"in 2026, our focus is on\nbringing\" ZoomInfo's \"all-in-one AI platform for go-to-market teams . . . to\nour customers at scale.\"\n\nAs alleged, ZoomInfo's customer retention declined as customers were rejecting\nZoomInfo's AI products.\n\nWhy did ZoomInfo's Stock Drop?\n\nOn May 11, 2026, ZoomInfo announced its Q1 2026 results and slashed its 2026\nrevenue guidance from $1.247-$1.267 billion to $1.185-$1.205 billion. ZoomInfo\nrevealed that its customer growth \"regressed\" due to \"AI and agentic\nconfusion\" leading to \"a pause in [customers'] purchasing decisions[.]\"\n\nThis news caused the price of ZoomInfo stock to decline $1.98 per share, or\n32.78%, from a closing price of $6.04 per share on May 11, 2026, to $4.06 per\nshare on May 12, 2026.\n\nClick here for more information:\nhttps://www.bfalaw.com/cases/zoominfo-class-action-lawsuit.\n\nWhat Can You Do?\n\nIf you invested in ZoomInfo, you may have legal options and are encouraged to\nsubmit your information to the firm.\n\nAll representation is on a contingency fee basis; there is no cost to you.\nShareholders are not responsible for any court costs or expenses of\nlitigation. The firm will seek court approval for any potential fees and\nexpenses.\n\nSubmit your information by visiting:\n\nhttps://www.bfalaw.com/cases/zoominfo-class-action-lawsuit\n\nOr contact:\n\nAdam McCall\nadam@bfalaw.com\n212.789.3619\n\nWhy Bleichmar Fonti & Auld LLP?\n\nBFA is a leading international law firm representing plaintiffs in securities\nclass actions and shareholder litigation. It has been named a top plaintiff\nlaw firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have\nbeen named \"Elite Trial Lawyers\" by the National Law Journal, \"Litigation\nStars\" by Benchmark Litigation, among the top \"500 Leading Plaintiff Financial\nLawyers\" by Lawdragon, \"Titans of the Plaintiffs' Bar\" by Law360 and\n\"SuperLawyers\" by Thomson Reuters.\n\nMost recently, The Legal 500 awarded BFA the most client satisfaction\naccolades of any plaintiff's securities litigation law firm, with clients\nnoting: \"[t]here is no better service provider in the practice area,\" \"[t]he\ninterest of the client is always front and center,\" and \"[t]here isn't a\nbetter firm in this space.\" One testimonial described the firm as \"nimble and\nentrepreneurial,\" with a \"relentless focus on adding value for clients.\"\n\nAmong its recent notable successes, BFA recovered over $900 million in value\nfrom Tesla, Inc.'s Board of Directors, as well as $420 million from Teva\nPharmaceutical Ind. Ltd.\n\nFor more information about BFA and its attorneys, please visit\nhttps://www.bfalaw.com.\n\nhttps://www.bfalaw.com/cases/zoominfo-class-action-lawsuit\n\nAttorney advertising. Past results do not guarantee future outcomes.\n\nSOURCE: Bleichmar, Fonti, & Auld LLP\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/gtm-securities-zoominfo-shareholders-who-lost-money-after-ai-int-1209352)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nACSYntRla","title":"$GTM Securities: ZoomInfo Shareholders Who Lost Money after AI Integration Revelation are Notified to Protect their Rights in Securities Fraud Class Action","author":"ACCESSWIRE","ticker":"GTM","created":"2026-08-20T11:07:01.085Z","tickers":["GTM"],"exchange":"NASDAQ","article_body":"A securities fraud class action lawsuit has been filed on behalf of ZoomInfo\ninvestors after its stock plummeted nearly 33% because ZoomInfo allegedly\nmisled investors regarding its customer retention.\n\nNEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / August\n20, 2026 / Leading securities law firm Bleichmar Fonti & Auld LLP\n(https://pr.report/pa9w) announces that a class action lawsuit has been filed\nagainst ZoomInfo Technologies Inc. (NASDAQ:GTM) and certain of the Company's\nsenior executives for securities fraud after its significant stock drop\nresulting from potential violations of the federal securities laws.\n\nIf you invested in ZoomInfo, you are encouraged to obtain additional\ninformation by visiting:\nhttps://www.bfalaw.com/cases/zoominfo-class-action-lawsuit.\n\nKey Details of the ZoomInfo ($GTM) Class Action:\n*\nLead Plaintiff Deadline: August 24, 2026\n*\nAlleged Misconduct: Securities fraud alleging that ZoomInfo misled investors\nregarding the impact of ZoomInfo's AI-integrated products on customer\nretention\n*\nStock Drop: May 12, 2026 - 33% Stock Drop\n*\nCourt: U.S. District Court for the Western District of Washington\n*\nAction: Contact BFA Law (https://pr.report/pa9y) to discuss your rights\n\nInvestors have until August 24, 2026 to ask the Court to be appointed to lead\nthe case. The complaint asserts securities fraud claims under Sections 10(b)\nand 20(a) of the Securities Exchange Act of 1934 on behalf of investors in\nZoomInfo securities. The class action is pending in the U.S. District Court\nfor the Western District of Washington. It is captioned Tejeda v. ZoomInfo\nTechnologies et al., No. 26-cv-05696.\n\nWhy is ZoomInfo Being Sued for Securities Fraud?\n\nZoomInfo has been sued for securities fraud following a significant stock drop\nresulting from potential violations of the federal securities laws. The\ndecline in ZoomInfo's stock price caused significant losses to investors.\n\nZoomInfo provides go-to-market (\"GTM\") intelligence and a customer engagement\nplatform for sales, marketing, operations, and recruiting professionals.\n\nThroughout the relevant period, ZoomInfo allegedly stated that \"the demand for\nAI for GTM is evident up and down our customer stack.\" According to ZoomInfo,\nits \"innovative go-to-market AI\" was \"driving stronger daily engagement from a\ndiverse set of go-to-market personas.\"\n\nOn February 9, 2026, ZoomInfo issued its 2026 revenue guidance \"in the range\nof $1.247 billion to $1.267 billion,\" because \"in 2026, our focus is on\nbringing\" ZoomInfo's \"all-in-one AI platform for go-to-market teams . . . to\nour customers at scale.\"\n\nAs alleged, ZoomInfo's customer retention declined as customers were rejecting\nZoomInfo's AI products.\n\nWhy did ZoomInfo's Stock Drop?\n\nOn May 11, 2026, ZoomInfo announced its Q1 2026 results and slashed its 2026\nrevenue guidance from $1.247-$1.267 billion to $1.185-$1.205 billion. ZoomInfo\nrevealed that its customer growth \"regressed\" due to \"AI and agentic\nconfusion\" leading to \"a pause in [customers'] purchasing decisions[.]\"\n\nThis news caused the price of ZoomInfo stock to decline $1.98 per share, or\n32.78%, from a closing price of $6.04 per share on May 11, 2026, to $4.06 per\nshare on May 12, 2026.\n\nClick here for more information:\nhttps://www.bfalaw.com/cases/zoominfo-class-action-lawsuit.\n\nWhat Can You Do?\n\nIf you invested in ZoomInfo, you may have legal options and are encouraged to\nsubmit your information to the firm.\n\nAll representation is on a contingency fee basis; there is no cost to you.\nShareholders are not responsible for any court costs or expenses of\nlitigation. The firm will seek court approval for any potential fees and\nexpenses.\n\nSubmit your information by visiting:\n\nhttps://www.bfalaw.com/cases/zoominfo-class-action-lawsuit\n\nOr contact:\n\nAdam McCall\nadam@bfalaw.com\n212.789.3619\n\nWhy Bleichmar Fonti & Auld LLP?\n\nBFA is a leading international law firm representing plaintiffs in securities\nclass actions and shareholder litigation. It has been named a top plaintiff\nlaw firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have\nbeen named \"Elite Trial Lawyers\" by the National Law Journal, \"Litigation\nStars\" by Benchmark Litigation, among the top \"500 Leading Plaintiff Financial\nLawyers\" by Lawdragon, \"Titans of the Plaintiffs' Bar\" by Law360 and\n\"SuperLawyers\" by Thomson Reuters.\n\nMost recently, The Legal 500 awarded BFA the most client satisfaction\naccolades of any plaintiff's securities litigation law firm, with clients\nnoting: \"[t]here is no better service provider in the practice area,\" \"[t]he\ninterest of the client is always front and center,\" and \"[t]here isn't a\nbetter firm in this space.\" One testimonial described the firm as \"nimble and\nentrepreneurial,\" with a \"relentless focus on adding value for clients.\"\n\nAmong its recent notable successes, BFA recovered over $900 million in value\nfrom Tesla, Inc.'s Board of Directors, as well as $420 million from Teva\nPharmaceutical Ind. Ltd.\n\nFor more information about BFA and its attorneys, please visit\nhttps://www.bfalaw.com.\n\nhttps://www.bfalaw.com/cases/zoominfo-class-action-lawsuit\n\nAttorney advertising. Past results do not guarantee future outcomes.\n\nSOURCE: Bleichmar, Fonti, & Auld LLP\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/gtm-securities-zoominfo-shareholders-who-lost-money-after-ai-int-1209352)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved."},"type":"article","timestamp":"2026-08-20T11:07:01.132923889Z","server_sent_at_ms":1787224021132},"received_at":"2026-08-20T11:07:01.254Z","source_url":"https://www.accessnewswire.com/newsroom/en/business-and-professional-services/gtm-securities-zoominfo-shareholders-who-lost-money-after-ai-int-1209352"},"analysis":{"id":"112731","press_release_id":"123754","analysis_json":{"industry":null,"redFlags":[],"eventType":"legal_litigation","narrative":"Bleichmar Fonti & Auld LLP announced a class action lawsuit against ZoomInfo Technologies Inc. on behalf of investors.\n\nThe lawsuit alleges securities fraud related to misleading statements regarding the impact of AI-integrated products on customer retention.\n\nThe suit follows a 32.78% stock drop on May 12, 2026, after ZoomInfo slashed its 2026 revenue guidance from $1.247-$1.267 billion to $1.185-$1.205 billion.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation regarding ZoomInfo -- suppress."},"keyFigures":null,"quotedText":"","namedEntities":{"people":[{"name":"Adam McCall","role":"Contact"}],"products":[],"companies":[{"name":"ZoomInfo Technologies Inc.","ticker":"GTM","relationship":"target"},{"name":"Bleichmar Fonti & Auld LLP","relationship":"plaintiff law firm"},{"name":"Tesla, Inc.","relationship":"other"},{"name":"Teva Pharmaceutical Ind. Ltd.","relationship":"other"}],"dollarAmounts":[{"amount":"$1.247 billion to $1.267 billion","context":"original 2026 revenue guidance"},{"amount":"$1.185-$1.205 billion","context":"slashed 2026 revenue guidance"},{"amount":"$1.98 per share","context":"stock price decline"},{"amount":"$6.04 per share","context":"closing price on May 11, 2026"},{"amount":"$4.06 per share","context":"closing price on May 12, 2026"},{"amount":"$900 million","context":"value recovered from Tesla, Inc.'s Board of Directors"},{"amount":"$420 million","context":"value recovered from Teva Pharmaceutical Ind. Ltd."}]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Bleichmar Fonti & Auld LLP. No new disclosure from the issuer; no certified class or settlement. Standard solicitation for lead plaintiffs."},"tickerRelevance":{"others":[],"primary":"GTM"},"globalImportance":15,"audienceRelevance":20,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Bleichmar Fonti & Auld LLP announced a class action lawsuit against ZoomInfo Technologies Inc. on behalf of investors.\n\nThe lawsuit alleges securities fraud related to misleading statements regarding the impact of AI-integrated products on customer retention.\n\nThe suit follows a 32.78% stock drop on May 12, 2026, after ZoomInfo slashed its 2026 revenue guidance from $1.247-$1.267 billion to $1.185-$1.205 billion.","key_figures":null,"named_entities":{"people":[{"name":"Adam McCall","role":"Contact"}],"products":[],"companies":[{"name":"ZoomInfo Technologies Inc.","ticker":"GTM","relationship":"target"},{"name":"Bleichmar Fonti & Auld LLP","relationship":"plaintiff law firm"},{"name":"Tesla, Inc.","relationship":"other"},{"name":"Teva Pharmaceutical Ind. Ltd.","relationship":"other"}],"dollarAmounts":[{"amount":"$1.247 billion to $1.267 billion","context":"original 2026 revenue guidance"},{"amount":"$1.185-$1.205 billion","context":"slashed 2026 revenue guidance"},{"amount":"$1.98 per share","context":"stock price decline"},{"amount":"$6.04 per share","context":"closing price on May 11, 2026"},{"amount":"$4.06 per share","context":"closing price on May 12, 2026"},{"amount":"$900 million","context":"value recovered from Tesla, Inc.'s Board of Directors"},{"amount":"$420 million","context":"value recovered from Teva Pharmaceutical Ind. Ltd."}]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-08-20T11:43:09.516Z","global_importance":15,"audience_relevance":20,"importance_components":{"tickerTier":"small-mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":null,"modelName":"glm-4.7"}}